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Abstract
Quorum sensing (QS) is the ability of some bacteria to detect and to respond to population density through signalling molecules.
QS molecules are involved in motility and cell aggregation mechanisms in diseases such as sepsis. Few biomarkers are currently
available to diagnose sepsis, especially in high-risk conditions. The aim of this study was the development of new analytical
methods based on liquid chromatography-mass spectrometry for the detection and quantification of QS signalling molecules,
including N-acyl homoserine lactones (AHL) and hydroxyquinolones (HQ), in biofluids. Biological samples used in the study
were Pseudomonas aeruginosa bacterial cultures and plasma from patients with sepsis. We developed two MS analytical
methods, based on neutral loss (NL) and product ion (PI) experiments, to identify and characterize unknown AHL and HQ
molecules. We then established a multiple-reaction-monitoring (MRM) method to quantify specific QS compounds. We vali-
dated the HPLC-MS-based approaches (MRM-NL-PI), and data were in accord with the validation guidelines. With the NL and
PI MS-based methods, we identified and characterized 3 and 13 unknown AHL and HQ compounds, respectively, in biological
samples. One of the newly found AHL molecules was C12-AHL, first quantified in Pseudomonas aeruginosa bacterial cultures.
The MRM quantitation of analytes in plasma from patients with sepsis confirmed the analytical ability of MRM for the
quantification of virulence factors during sepsis.
Keywords Quorum sensing molecules . Homoserine lactones . Hydroxyquinolones . Pseudomonas aeruginosa . Mass











HPLC High-performance liquid chromatography
H P L C - T Q
MS
High-performance liquid chromatography–
triple quadrupole mass spectrometry
HRMS High-resolution mass spectrometry
HQs Hydroxyquinolone signalling molecules
IS Internal standard
LB Luria-Bertani
LLOQ Lower limit of quantification
LTQ Linear trap quadrupole
M9 Mineral medium
Federica Dal Bello and Michael Zorzi contributed equally to this work.
* Federica Dal Bello
federica.dalbello@unito.it
1 Department of Molecular Biotechnology and Health Sciences,
University of Turin, via Pietro Giuria 5, 10, 125 Torino, Italy
2 Department of Surgical Science Anesthesia and Critical Care, AOU
Città della Salute e della Scienza, University of Turin, Corso
Bramante 88, 10, 126 Torino, Italy
3 Department of Translational Medicine, University of Eastern
Piedmont, Via Solaroli, 17, 28, 100 Novara, Italy
4 Department of Chemistry, University of Turin, via Pietro Giuria 5,
10, 125 Torino, Italy
5 Department of Biotechnology and Life Sciences, University of
Insubria, Via J.H. Dunant 3, 21, 100 Varese, Italy
Analytical and Bioanalytical Chemistry
https://doi.org/10.1007/s00216-020-03040-6
MOF Multi-organ failure







TQ MS Triple quadrupole mass spectrometer
UHPLC Ultra-high-performance
liquid chromatography
ULOQ Upper limit of quantification
Introduction
Bacteria have the ability to interact with each other through a
complex language called “quorum sensing” (QS) [1–3].
Literally, QS means “detection of the quorum”, and it refers
to the ability of bacteria to monitor their population density,
and consequently to control their gene expression, through the
control of the amount of specific molecules, called
autoinducers (AIs), in their living environment [4–6]. AIs
are small and diffusible molecules produced by bacteria, re-
leased and accumulated in the extracellular environment.
When many AIs are produced and stored, and their concen-
tration reaches a threshold level (the quorum), the bacterial
population is able to activate or to repress target genes [7].
This mechanism enables the survival of a bacterial population
in a constantly changing environment (temperature, pH and
osmotic concentration variations, and nutrient availability)
thanks to the synthesis of new proteins. QS-mediated changes
are energetically expensive, and they are advantageous only
when cells have reached a high-density population [8, 9].
Gram-positive and Gram-negative bacteria use different
means of communication [10]. Gram-positive bacteria pro-
duce oligopeptides as QS autoinducer molecules, while
Gram-negative bacteria use others QS signal molecules
[11–13]. The most abundant and common are N-acyl
homoserine lactones (AHLs) [14, 15]. These molecules are
characterized by a γ-lactone cycle which is N-acylated in
the α position and an acyl chain (indicated as R-chain in
Fig. 1). Chain length is the signal specificity factor for
bacteria, and the chain typically contains between 4 and 16
carbon atoms. The presence of an oxo or a hydroxy group
linked to the third carbon atom of the chain is a further element
of distinction.
In some human oppor tunis t ic pathogens , l ike
Pseudomonas aeruginosa, the secretion of the most abundant
AHL QS signalling molecules N-(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C12-AHL) and N-butanoyl-L-
homoserine lactone (C4-AHL) depends on the regulatory cir-
cuit systems Las or Rhl [16, 17]. In bacteria, those systems
control the expression of different virulence genes in a popu-
lation density-dependent manner.
In addition to AHLs, Gram-negative bacteria such as
Pseudomonas aeruginosa use a hydroxyquinolone molecule
(HQ), the 2-heptyl-3-hydroxy-4(1H)-quinolone (known as
PQS or C7 HQ), as a QS signalling compound [18, 19]. The
basic structure of quinolone molecules consists of a bicyclic
ring. The length of the acyl chain (marked as R-chain in Fig.
2) ranges between seven and 11 carbon atoms; the presence of
a hydroxy or a carbonyl group in position 1 of the bicyclic ring
is a further element of distinction.
As described above, AHLs and HQs are the most abundant
QS signalling molecules produced by Gram-negative bacteria.
Many studies in the literature have aimed to describe and
quantify well-known or new QSmolecules in bacterial culture
or human samples [20–35]. There are two main methods for
obtaining the measurements: biosensors [21–23, 26, 30, 31]
and methods based on liquid chromatography coupled to
(high-resolution) mass spectrometry [20, 23–25, 27–29,
32–36]. Biological biosensors reach very low sensitivity, with
a pg/mL (fmol) limit of detection, and are highly specific for a
single QS (AHL or HQ). However, they miss unknown mol-
ecules, and the quantitation demonstrates low accuracy [32].
On the contrary, mass spectrometry-based methods, both
targeted and untargeted, offer accurate quantitation of AHL
and HQ compounds. During the past few years, many LC-MS
methods have been developed that exploit several stationary
and mobile phases, using both targeted and untargeted MS
approaches. Some studies showed a very low limit of quanti-
tation (pg/mL) and good selectivity, optimizing a short liquid
chromatography separation both for AHLs, furthermore enan-
tiomeric, and for HQs [27–29, 33–36]. Other research groups














Fig. 1 N-Acyl homoserine lactone generic structure. a Non-substituted
N-acyl homoserine-L-lactone (Cn-HSL) acyl chain; b N-(3-
hydroxyacylhomoserine)-L-lactone (3-OH-Cn-HSL) acyl chain; c N-(3-
oxoacylhomoserine)-L-lactone (3-oxo-Cn-HSL) acyl chain. The length is
variable, generally n = 4–14
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provide the quantitation of a higher number of molecules [24]
or to identify new AI molecules with an untargeted high-
resolution MS approach [32].
Summarizing, there are a huge number of QS molecules
produced by bacteria, and the identification, characterization
and accurate quantitation of peculiar and unknown QS are still
needed.
The purpose of this work was to develop and validate
HPLC-TQ MS chemical class-specific methods able to iden-
tify and quantify quorum sensing molecules (AHLs and HQs)
in different matrices, such as bacterial cultures and biological
plasma samples. In order to characterize and identify un-
known AHL and HQ signalling molecules, the aim of the
research was the development of an MS analytical method
based on neutral loss (NL) and product ion (PI) experiments.
A tandem mass spectrometry method based on a multiple
reaction monitoring (MRM) approach was developed for the
quantitation of AHLs and HQs in bacterial cultures and bio-
logical plasma samples. To ensure greater reliability of ana-
lytical data, fragmentation pathways of analytes of interest and
the exact mass of detected unknown molecules were con-
firmed by high-resolution mass spectrometry (LTQ-
Orbitrap). The developed MRM method was firstly applied
to quantify the QS molecules in Pseudomonas aeruginosa
cultures obtained from two different strains [37], and with
our NL and PI methods we aimed to elucidate whether other
QS molecules were involved in the protection mechanism
used by bacteria. Secondly, the MRM method was applied
to pa thology plasma samples (before and af te r
hemoperfusion) of patients affected by sepsis-related multi-
organ failure (MOF), which is associated with high mortality.
To our knowledge, this study is the first to provide a tandem
mass spectrometry quantitation of both AHLs and HQs in
plasma samples from patients with sepsis.
Materials and methods
Chemicals
Analytical standards (purity >98%) of 2-heptyl-3-hydroxy-
4(1H)-quinolone (C7 HQ), N-(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C12-AHL), N-hexanoyl-L-
homoserine lactone-D3 (ND3) and N-butanoyl-L-
homoserine lactone (C4-AHL) were purchased from Merck
KGaA (Darmstadt, Germany). Stock solutions were prepared
with a concentration of 1000 mg/L using methanol and were
stored at −4 °C until use. Further dilutions were obtained in
0.1% formic acid in water/acetonitrile 60:40. All aqueous so-
lutions were prepared with HPLC-grade water from a Milli-Q
Academic System (Millipore, Burlington, MA, USA). Ethyl
acetate HPLC-MS grade, acetonitrile and methanol hyper-
grade for LC-MS, and formic acid were purchased from
VWR International (Radnor, PA, USA).
Instrumentation
Separation and analysis of all analytes and samples were
achieved upon an HPLC-TQ MS platform. HPLC consisted
of a Shimadzu Nexera X2 Ultra High Performance Liquid
Chromatography (UHPLC) system (Shimadzu, Kyoto,
Japan) coupled for identification and quantitation to a
QTRAP 5500 system (Sciex, Darmstadt, Germany). The triple
quadrupole was equipped with a Turbo V™ Source (ESI
mode) which utilized nitrogen and air as sheath and reagent
gas, respectively. To verify the exact mass values, we used an
LTQ-Orbitrap high-resolution mass spectrometer (Thermo
Scientific, Waltham, MA. USA) within mass accuracy of
±3 ppm and resolution of 30 k.
HPLC parameters
To investigate AHL and HQ signalling molecules in biologi-
cal samples, different chromatographic gradients were carried
out. However, HPLC methods had several features in com-
mon. The analytical column used was a Phenomenex Luna
C18 reversed-phase column (150 × 2.1 mm i.d., 3 μm parti-
cles). Sample injection volume was 10 μL. Autosampler and
oven temperatures were set at 15 °C and 45 °C, respectively,
for the duration of all analyses.
For AHLs, HPLC-TQ MS analysis eluents were formic
acid 0.1% in water (solvent A) and in acetonitrile (solvent
B). Flow rate was set at 200 μL/min. For bacterial cultures,
the mixture percentage changed from 40% solvent B to 100%
solvent B during the first 35 min, maintained for 10 min, and












Fig. 2 Generic structure of
quinolone signalling molecules. a
2-Alkyl-4-hydroxyquinolone N-
oxide with a variable chain length
(C7–C9); b 2-alkyl-4(1H)-quino-
lone alkyl chain (the chain length
is variable, C7–C11); c 2-alkyl-3-
hydroxy-4(1H)-quinolone
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plasma samples, the HPLC run started from 40% solvent B,
increased to 100% solvent B in 19min, maintained for 10min,
and then returned to the starting conditions. Bacterial cultures
were more complex than plasma samples and required us to
obtain a satisfactory chromatographic separation with slower
solvent variation during gradient elution (see Electronic
Supplementary Material [ESM] Fig. S1).
Chromatographic separation for the MRM and PI analysis
of C7 HQ in bacterial cultures and plasma samples was
achieved using 2-picolinic acid 2 mM/formic acid 0.1% in
water (solvent C) and acetonitrile 0.1% formic acid (solvent
D). 2-Picolinic acid acted as a bidentate chelator, preventing
peak distortion caused by C7 HQ, an iron chelator molecule
[33]. Gradient started from 20% solvent D, up to 100% sol-
vent D in 12 min; then the column returned to the starting
conditions. Flow rate was 250 μL/min.
MS settings
The LC effluent was delivered to the Turbo V™ Source (ESI
positive ionization mode) using nitrogen as the sheath (GS1)
and curtain (CUR) gas and air as reagent (GS2) gas, respec-
tively. The mass spectrometer parameters were as follow:
CUR 26 arbitrary units (arb), GS1 45 arb, GS2 50 arb, ion
spray voltage 5.5 kV and ion spray temperature 500 °C.
Considering all the possible MS experiments developed,
each sample was analysed five times: MRM-NL-PI for AHL
analysis, andMRM-PI for HQ analysis. TheMRM,NL and PI
parameters are listed in Table 1. For MRM acquisition, we
selected one qualitative and one other quantitative (bold in
Table 1) transition for each analyte. The instrument parame-
ters are listed in ESM Tables S1 and S2.
Bacterial cultures and biological samples
Two Pseudomonas aeruginosa strains were selected as repre-
sentatives of bacterial cultures: wild-type PAO1 strain and its
isogenic mutant RhlI defective in the synthesis of C4-AHL
previously obtained [37, 38].
Different Pseudomonas aeruginosa PAO1 and RhlI bacte-
rial cultures were prepared and analysed: (i) wild-type bacte-
rial culture grown in Luria-Bertani (LB) broth (rich in nutri-
ents), WT-LB; (ii) wild-type bacterial culture grown in the
mineral medium (M9) culture (low in nutrients), WT-M9;
(iii) RhlI mutant bacterial culture grown in the LB broth,
RhlI-LB; and IV) RhlI mutant bacterial culture grown in the
M9 culture, RhlI-M9.
For the application of the MRM-NL-PI methods devel-
oped, we analysed plasma samples from healthy people and
patients affected by MOF. All the patients involved in the
present study expressed their consent and their will based on
their awareness of the proposed study of their biological
fluids, freely deciding whether to accept. All the procedures
followed in the work were carried out in accordance with the
ethical standards of our institutional, the national research
committee and with the Code of Ethics of the World
Medical Association (1964 Helsinki declaration).
Sample preparation and enrichment
All the bacteria media were prepared as described by Orlandi
et al. [37]. Bacterial cultures were centrifuged for 10 min at
12,000 rpm and RT, and the supernatants were then collected
and filtered (Minisart RC15 Ø 0.20 mm; Sartorius) before
extraction (see below).
Samples from patients with MOF were taken during a
weekly dialysis session, and they were collected before (t0),
after 2 h (t2h) and after 24 h (t24h) of hemoperfusion, and those
from healthy people during a draw in the morning. Plasma
was separated from blood with an ultracentrifuge and then
stored refrigerated at 4 °C until use. Samples were processed
and analysed within 2 days.
Before extraction of the analytes from samples, 200 μL of
bacterial culture medium or plasma was spiked with ND3
internal standard (IS) to a final concentration of 200 μg/L.
The internal standard was used to evaluate injection only.
All of the analytical validation was done on the basis of ex-
ternal standard calibration. Samples were extracted twice in
Table 1 Multiple reaction monitoring (MRM), neutral loss (NL) and product ion (PI) scan parameters for AHL and HQ analysis (bolded transitions
were used as quantitative ones)
Analyte Precursor ion [M +H]+ Product ion [M +H]+ Molecule family MS mode Δm (Da)
MRM 3-oxo-C12-AHL 298.2 102.2 AHL NL 101.0
298.2 197.2 PI 102.0
C4-AHL 172.1 102.2 HQ PI 175.0
172.1 71.1
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succession with 1mL of ethyl acetate [39]. After each addition
of organic solvent, the sample was centrifuged at 5000 × g
for 5 min at RT, and the organic fractions were collected and
dried under a gentle stream of N2 with heating at 40 °C.
Finally, the residue was reconstituted in 100 μL of 0.1%
formic acid in water/acetonitrile 60:40.
HPLC-TQ MS method validation
The validation procedure was performed on the HPLC-TQ
MS platform, according to the European Medicines Agency
(EMA) and Eurachem guidelines [40, 41]. The calibration
curves were run using a matrix free of quorum sensing mole-
cules (plasma samples from healthy people) by performing the
standard addition method. The absence of analytes of interest
within the matrix used (QS-free matrix) for the method vali-
dation was verified through the LTQ-Orbitrap high-resolution
power platform.
For method validation, different parameters were evaluat-
ed: selectivity, recovery, carry-over, intra-run accuracy and
precision, limit of quantitation (LOQ), lower LOQ (LLOQ),
upper LOQ (ULOQ), stability to freeze-thaw cycle and cali-
bration model. The last one, in particular, was evaluated using
a stepwise approach as described elsewhere [42], and the lin-
earity of the calibration curves using an R routine developed
by Desharnais et al. [43, 44]: Firstly, the heteroscedasticity of
data points was tested by performing an F-test on the variance
of the area ratios at the lowest and highest calibration levels.
The heteroscedasticity study was also integrated with the
Levene test (in the version modified by Brown and
Forsythe). Then, a partial F-test was used to evaluate whether
the calibration model followed a linear or quadratic trend [45].
The goodness of fit of the calibration model was finally eval-
uated by studying the normality of the standardized residuals
(with the Cramer von Mises test) and by performing the back-
calculation on the averaged signal from four replicates [43,
44].
For the validation of AHL molecules, C4-AHL and 3-oxo-
C12-AHL were selected as molecule class representatives,
whereas C7 HQ was used as a representative of HQ mole-
cules. For all the analyses, ND3 was used as injection
standard.
Selectivity (SEL%) was evaluated by comparing the chro-
matograms of six individual QS-free matrices and could be
below 20%. Recovery (REC%) was evaluated by relating the
responses of analytes in the extracted samples to those solu-
bilized in the injection solvent. The experiments were con-
ducted at LLOQ and ULOQ concentrations, depending on
the analyte. REC% was evaluated only for the MRM ap-
proach. The carry-over effect (CO%) was studied by compar-
ing the signal of the molecule of interest in QS-free matrix
after the injection of the highest concentration point of the
calibration curve. Values could be below 20% of the LLOQ
value. Accuracy (BIAS%) and precision (variation coefficient
CV%) of intraday (repeatability) were calculated in QS-free
matrix samples at three different concentrations carried out
five times. Values could be below 15%. Limit of quantitation
(LOQ) was determined by ten times the signal-to-noise ratio,
expressed as the absolute value of analyte concentration.
LLOQ and ULOQ were expressed as the experimentally low-
er and upper measured analyte concentrations, respectively.
Freeze-thaw stability (STAB%) was evaluated by comparing
freshly prepared processed samples frozen at −20 °C for three
cycles and thawed at RT in order to determine the freeze-thaw
stability of the AHL and HQ standards. The experiments were
evaluated at two concentrations, LLOQ and ULOQ. STAB%
ranged between 85% and 115%.
Results
Validation results
Validation results are summarized in Table 2 and presented in
ESM Section 2, “Validation tables and results”. All parame-
ters conformed to those suggested by EMA and Eurachem
guidelines.
Selectivity of each MS approach was satisfactory with a
value always below 20%, ranging between 0.50 and 16.5%.
No isomeric or isobaric interfering compound co-eluted with
the analytes, and no ion suppression was observed for the
AHL and HQ standard molecules.
The recovery calculated for the MRM approach ranged
between 34% and 61%. This was presumably correlated with
the presence of esterase enzymes in the plasma matrices, and
quorum sensing molecules, being esters, underwent partial
hydrolysis. However, using the calibration curves obtained
in plasma matrices, we overcame the issue.
Carry-over effect measurements demonstrated, for all MS
methods, that in a QS-free matrix sample, the area under the
curve (AUC) of the analytical standards was lower than 20%
of the corresponding LLOQ area.
The precision and accuracy of intraday runs were below
20% for the selected curve calibration points.
LOQ values for analytes ranged between 0.09 and
0.457 μg/L, and the MRM method showed the best LLOQ
value (0.4 μg/L).
Stability test parameters always fell within the acceptable
limits, and based on the results, the average stability % value
at each concentration level ranged between 85% and 117%.
Therefore, the plasma matrix was similarly stable at operative
condition temperatures as in freezing and thawing cycles with-
out affecting the concentration of the analyte.
The study of the calibration model provided concordant
results for all the analytes. Concerning the study of
heteroscedasticity, the F-test and the Levene test provided
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consistent results for all but two calibration sets, namely C4-
AHL-NL and C4-AHL-PI, for which the Levene test sug-
gested a homoscedastic trend (ESM Table S5). In both cases,
a more conservative approach was preferred, and the weight
was applied as suggested by the routine from Desharnais. The
weight for the heteroscedasticity was equal to 1/x2 in all cases.
Furthermore, all the calibration curves were confirmed to be
linear, with p values for the partial F-test above the signifi-
cance limit of 0.05. The goodness of the calibration models
was proved by the good results provided by the Cramer von
Mises test (p values always not significant) and the back-
calculation (deviations far below ±25% for all the models).
Finally, also the R-squared values (R2 > 0.990) demonstrated
how our model explained all of the variation in the response
variable around its mean.
Sample results
With the development of three different MS approaches, we
detected and quantified both unknown and known AHL and
HQ molecules in biological samples.
For AHL unknown structures, we used the NL and PI ap-
proaches. In NL experiments, precursor and product ions were
monitored for the loss of 101 Da which corresponds to 2-
amino-gamma butyrolactone. In PI mode, Q3 was set to detect
only m/z 102 corresponding to the elemental composition of
protonated 2-amino-gamma butyrolactone (Fig. 3).
For new molecules belonging to the HQ family, we used a
PI methodology selecting as product ion the protonated radi-
cal ion 2-methyl-3-hydroxyquinolin-4-one with anm/z ratio of
175 (Fig. 3).
Product ion
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Fig. 3 TQMS/MS selective acquisition modes. M1 is a generic structural
formula of a protonated molecule belonging to the N-acyl homoserine
lactones (AHLs) family. R varies between 4 and 16 carbon atoms. M2 is
the product ion formed after the neutral loss of a 2-amino-gamma
butyrolactone molecule (MW 101 Da). M2′ is the product ion with m/z
102. Analogously, N1 is a general structural formula of compounds be-
longing to the hydroxyquinolone signalling molecule (HQ) family. R
varies between 7 and 11 carbon atoms. N2′ is the product ion with m/z
175
Table 2 Validation parameters for 3-oxo-C12-AHL, C4-AHL and C7 HQ obtained in MRM, NL, PI HPLC-MS approaches (NM= not measured)
Validation parameter Conc. (μg/L) 3-oxo-C12-AHL C4-AHL C7 HQ
MRM NL PI MRM NL PI MRM PI
SEL% 8.12 0.50 1.10 5.65 1.63 2.54 16.5 4.73
REC% LLOQ 45.5 NM NM 51.0 NM NM 49.9 NM
ULOQ 53.7 NM NM 60.9 NM NM 34.3 NM
CO% 7.10 0.57 1.29 8.90 1.65 0.87 16.1 2.98
I-R BIAS% LLOQ 1.65 3.66 2.40 0.61 2.72 3.59 2.11 2.28
50.0 9.88 7.77 3.05 5.32 1.84 4.32 2.27 8.68
ULOQ 1.61 3.63 4.97 0.23 0.80 6.98 4.14 2.27
I-R CV% LLOQ 12.4 0.87 12.9 18.4 25.0 13.7 26.5 11.9
50.0 17.1 8.87 5.91 10.8 19.1 16.6 18.4 1.72
ULOQ 14.3 4.98 12.0 15.6 20.9 18.1 20.7 5.84
LOQ μg/L 0.090 0.293 0.117 0.271 0.457 0.066 0.151 0.385
LLOQ μg/L 0.40 5.00 1.00 0.40 5.00 1.00 0.40 1.00
ULOQ μg/L 400 400 300 400 400 300 200 300
STAB% LLOQ 106 89.5 86.0 97.3 91.1 88.9 115 90.2
ULOQ 101 88.6 90.2 102 86.9 95.5 117 96.2
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Unknown AHL and HQ signalling molecules, identified
and characterized in an untargeted approach using NL and
PI modes, were confirmed by the use of the HRMS tool
(LTQ-Orbitrap), and to better describe them we studied the
fragmentation pathways of analytical standards (see
“Discussion” section).
Two unknown AHL species were detected both in
P. aeruginosa bacterial cultures and patients’ plasma samples:
3-oxo-C10-AHL (C14H23NO4, m/z 270.1705) and C12-AHL
(C16H30NO3, m/z 284.2226). One other, C6-AHL
(C10H17NO3, m/z 200.1287), was present in bacterial cultures
only (see ESM for chemical and structural formulas,
Table S3).
In the bacterial cultures, 13 unknown HQ molecules were
identified by the PI approach and confirmed by HRMS anal-
ysis: C2-HQ (C11H11NO2, m/z 190.0868), C3-HQ
(C12H13NO2, m/z 204.1024), C4-HQ (C13H15NO2, m/z
218.1181), C5-HQ (C14H17NO2, m/z 232.1337), C6-HQ
(C15H19NO2, m/z 246.1494), C6:1-HQ (C15H17NO2, m/z
244.1337), C7:1-HQ (C16H19NO2, m/z 258.1494), C8-HQ
(C17H23NO2, m/z 274.1807), C8:1-HQ (C17H21NO2, m/z
272.1650), C9-HQ (C18H25NO2, m/z 288.1936), C9:1-HQ
(C18H23NO2, m/z 286.1807), C11-HQ (C20H29NO2, m/z
316.2276) and C11:1-HQ (C20H27NO2, m/z 314.2120) (see
ESM for chemical and structural formulas, Table S4).
The detected compounds were then semi-quantified in bac-
terial cultures using the validated calibration curves of C4-
AHL and 3-oxo-C12-AHL, depending on chain length and
on hydroxylation grade, to quantify AHL molecules, and of
C7 HQ to quantify HQ compounds. For the quantification of
both AHL and HQ molecules, we used the calibration curves
obtained with the PI MS methods because of their lower
LLOQ (1 μg/L for PI vs. 5 μg/L for NL). The results are listed
in Tables 3 (AHL) and 4 (HQ).
Finally, the known analytes (C4-AHL, 3-oxo-C12-AHL
and C7 HQ) were quantified in bacterial cultures and patients’
plasma samples with the validated HPLC-TQ MRM MS
method, and the results are shown in Tables 5 and 6.
Discussion
Method validation discussion
The three acquisition techniques showed different LLOQ
values and linearity ranges, and MRM was the one which
allowed the wider calibration range, with an LLOQ equal to
0.4 μg/L (for PI and NL, LLOQ was 1 μg/L and 5 μg/L,
respectively). It is known that the MRM approach has a better
sensitivity with respect to NL and PI [46], moreover balanced
by the better diagnostic possibilities of these different
approaches.
Independently from the MS/MS, the class of the targeted
molecule and the calibration range, the heteroscedasticity tests
showed concordant results. Both the F-test and the Levene test
on the variance of the calibration replicates demonstrated the
need for a 1/x2 weight. The only exceptions are the NL and PI
experiments performed for C4-AHL, for which the Levene
Table 4 Pseudomonas aeruginosa culture concentrations (expressed in
μg/L) of the unknown HQ molecules semi-quantified using the linear
equation of the PI validated MS approach
Concentration (μg/L)
C2 HQ C3 HQ C4 HQ C5 HQ C6 HQ C6:1 HQ
WT-LB ND 0.76 3.96 16.11 38.54 0.33
WT-M9 ND ND ND ND ND ND
RhlI-LB 11.15 98.76 33.14 232.45 145.45 17.02
RhlI-M9 ND ND ND ND ND ND
C7:1 HQ C8 HQ C8:1 HQ C9 HQ C9:1 HQ C11 HQ
WT-LB 24.07 81.44 1.93 182.57 26.98 1.57
WT-M9 ND ND ND ND ND ND
RhlI-LB 2.00 45.75 3.61 12.46 7.40 ND






WT wild type, RhlI mutant bacterium, M9 mineral medium, LB Luria-
Bertani broth, ND not detectable (<LLOQ)
Table 3 Pseudomonas aeruginosa culture concentrations (expressed in
μg/L) of the unknown AHL molecules semi-quantified using the linear
equation of the PI validated MS approach
Concentration (μg/L)
C6-AHL 3-oxo-C10-AHL C12-AHL
WT-LB 6.57 0.62 0.13
WT-M9 ND 0.72 0.70
RhlI-LB ND 0.52 ND
RhlI-M9 ND 2.89 ND
WT wild type, RhlI mutant bacterium, M9 mineral medium, LB Luria-
Bertani broth, ND not detectable (<LLOQ).
Table 5 Analyte concentrations (μg/L) measured in bacterial cultures
of Pseudomonas aeruginosa with the MRM approach
Concentration (μg/L)
C4-AHL 3-oxo-C12-AHL C7 HQ
WT-LB 5.36 3.66 357
WT-M9 nd 2.07 nd
RhlI-LB nd 2.17 736
RhlI-M9 nd 1.16 nd
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test suggested a homoscedastic trend. This was discordant
with the t-test output and also with the visual inspection of
the replicates, evidencing a progressively greater variance for
replicates of the higher calibration levels. Hence, a more con-
servative approach was preferred and a weight applied.
Furthermore, the verification of the linearity trend by means
of a partial F-test confirmed the linearity within the selected
calibration range, with all the p values above the cut-off limit
of 0.05. The goodness of the selected calibration model was
finally verified by high p values for the study of the normality
of the standardized residuals and the back-calculation at all the
calibration levels (ESM Tables S5 and S6).
Sample results discussion
Before starting with the identification and characterization of
unknown AHL and HQ molecules (presented in the section
“Sample results” and in ESM Tables S1 and S2), an investi-
gation using HRMS of fragmentation pathways of analytical
standards was carried out. As representatives of the AHL
class, we selected 3-oxo-C12-AHL and C4-AHL, and C7
HQ from the HQ family. ND3 as previously described was
used as IS. CID MS2 fragmentation schemes of C4-AHL, 3-
oxo-C12-AHL, C7 HQ and ND3 are presented in Fig. 4. As
mentioned before, AHL molecules shared the product ion m/z
102, and C7 HQ showed the peculiar product radical ion m/z
175 common for the HQ family.
Since the analysis of bacterial cultures and plasma samples
of patients were completed only 2 days after sampling and
handling, and samples were stored refrigerated at −4 °C, no
other pathogens should develop [33]. In this situation, the
unknown AHLs and HQs detected with the developed MS
methods resulted from P. aeruginosa bacteria or patients with
sepsis.
The chromatographic runs proposed here for AHL mole-
cules were much longer if compared with other analytical
methods. Ortoni and co-workers [27] used a 2.9-min-long
separation run to quantify 26 AHLs in bacterial cultures.
Readel et al. [36], with an acetonitrile isocratic run of
10 min, successfully separated six racemic L/D homoserine
lactones. Struss et al. [29] and Hoang et al. [35] developed a
17-min reversed-phase HPLC method to quantify AHL in
sputum of cystic fibrosis patients and bacterial cultures, re-
spectively. In particular, the group led by Hoang [35] present-
ed a green analytical method with the use of supercritical-fluid
chromatography (SFC), and performed an in-depth optimiza-
tion of the method. Unfortunately, SFC-TOF (Time of Flight)
is quite an expensive technology and requires a very skilled
operator. Although these methods showed a very low limit of
quantitation (pg/mL), with good selectivity and robustness,
they quantified well-known molecules belonging to the
AHL family (using analytical standards) [27, 35, 36] or a
limited number of analytes [29].
When the number of molecules increases and, more signif-
icantly, when unknown compounds should be identified and
characterized, the duration of the separation run is increased in
order to avoid analyte co-elution or ion suppression. The de-
veloped chromatographic run lasted 35 min, which is compa-
rable to that proposed byKumari et al. [24] for the detection of
ten AHLs. An untargeted high-resolution mass spectrometry
method for the identification of novel AHLs in eight different
bacterial cultures grown under different conditions was pro-
posed by Patel et al. [32]. They used a C18 column and a Q
Exactive high-resolution mass spectrometer, and within
Table 6 Analyte concentrations (μg/L) measured in plasma samples of patients with multi-organ failure (MOF) pathology with the MRM approach
Concentration (μg/L)
MOF#1 MOF#2
C4-AHL 3-oxo-C12-AHL C7 HQ C4-AHL 3-oxo-C12-AHL C7 HQ
t0 6.90 0.52 14.1 4.70 0.51 3.21
t2h 6.40 nd 10.1 3.70 0.55 4.17
t24h 6.10 nd 5.70 3.80 0.49 1.99
MOF#3 MOF#4
C4-AHL 3-oxo-C12-AHL C7 HQ C4-AHL 3-oxo-C12-AHL C7 HQ
t0 5.40 0.56 2.85 5.80 0.56 2.85
t2h 5.00 0.54 2.75 5.20 0.55 2.75
t24h 4.60 0.51 2.50 5.70 0.52 2.50
MOF#5 MOF#6
C4-AHL 3-oxo-C12-AHL C7 HQ C4-AHL 3-oxo-C12-AHL C7 HQ
t0 6.70 0.56 17.2 5.10 0.55 4.52
t2h 6.00 0.53 12.1 4.00 0.51 3.96
t24h 5.90 0.52 5.09 5.50 nd 4.16
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13 min they detected 23 AHLs, some of them never described
in the literature. Their method showed little overlapping and
tailing of chromatographic peaks; nevertheless, they achieved
a very low limit of detection for all analytes and performed the
identification of unexpected AHL molecules using a labelled
approach. As with our method, the MS/MS method for the
identification of AHLs was based on a peculiar product ion
with m/z 102.
The HQ separation run was shorter than that for AHLs, and
could be compared to those developed by Maurer et al. [28]
and Brewer et al. [34]. It lasted 12 min (Maurer 9′ and Brewer
8′), and the separation obtainedwith the use of 2-picolinic acid
was satisfactory (ESM Fig. S2). Although Maurer and co-
workers [28] used a mixture of acetic anhydride-pyridine to
derivatize C7-HQ, and the Brewer team [34] employed EDTA
as mobile aqueous phase, we preferred to follow the
Turnpenny recommendation [33] in order to obtain a good
shape of chromatographic peaks and consequently a possibly
more accurate quantification of the HQ compounds.
Therefore, we ran the chromatographic separation with the
use of 2-picolinic acid. Indeed, the EDTA molecule is not
suggested for MS analysis, since it is a non-volatile salt and
gives an ion suppression effect, and derivatization is not a
quantitative operation. On the contrary, 2-picolinic acid is
highly volatile and a bidentate chelating agent, and as
Turpnenny noted, the use of formic acid together with 2-
picolinic acid improved the ESI positive ionization of the
studied molecules [33].
As previously presented, we were able to detect and iden-
tify 13 HQs in bacterial cultures and plasma samples. Among
all the possible QSmolecules, the most highly expressed (high
concentration) was the C7 HQ. In minimal medium poor in
nutrients (W9), the C7 HQ species was the only one detected
in both the wild-type and the RhlI derivative bacterial cultures.
This finding supports the hypothesis that the knockout mutant,
unable to produce C4-AHL, intensified the production of this
signal molecule to promote bacterial cell growth. As for AHL
compounds, cells grown in LB broth showed the most abun-
dant content of HQ molecules with respect to M9 medium.
The detection of HQ molecules in biological samples is very
important because their concentration is related to the expres-
sion of many virulence factors and to the regulation of iron
usage inside the cells [47].
In addition to the importance of a good chromatographic
separation, the developed NL and PI MS approaches also
played a fundamental role in the identification of unknown
compounds. The unknown species C6-AHL was detected in
bacterial cultures only, with an empirical formula of
C10H17NO3, and accurate m/z of 200.1287 (confirmed with
the LTQ-Orbitrap system) is in agreement with Alayande et al.
Fig. 4 MS2 fragmentation pathways of N-(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C12-AHL), N-butanoyl-L-homoserine lac-
tone (C4-AHL), 2-heptyl-3-hydroxy-4(1H)-quinolone (C7 HQ) and N-
hexanoyl-L-homoserine lactone-D3 (ND3). Product ion m/z 102 and
product radical ion m/z 175 are the characteristic fragmentation products
of molecules belonging to AHL and HQ families, respectively
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[48]. The authors grew Pseudomonas aeruginosa PAO1 in
LB medium and evaluated the levels of AHL by LC-MS/
MS analysis. This work is among the very few on
P. aeruginosa that showed the detection of C6-AHL signal
molecule production, and the only report where C6-AHL was
detected in an amount greater than that of 3-oxo-C12-AHL.
They found for the first time that among the various signal
molecules, C4-AHL and C6-AHL played the most important
signalling role in the QS system of P. aeruginosa PAO1.
Moreover, the search for C6-AHL showed the presence of
three chromatographic peaks presumably corresponding to
three isomers. Even the known C4-AHL molecule
(C8H13NO3, m/z 172.0974) was detectable as two different
isomers when monitored using the NL approach. However,
the ability to discriminate between the isomers would require
a more detailed investigation using for example an NMR tech-
nique to obtain structural information. The analysis of HQ
molecules did not show any isomeric species.
Also, 3-oxo-C10-AHL was recognized in bacterial cul-
tures, and its amount was rather high, especially in RhlI-W9
samples. This indicates that in the absence of C4-AHL, bac-
teria can use this other molecule to communicate. Similar
results were obtained by Patel et al. [32] in Erwinia
carotovora culture grown in nutrient-rich medium.
Last but not least, we quantified C12-AHL in bacterial
samples, to our knowledge for the first time. In fact, other
research groups discovered novel AHL molecules in bacterial
cultures [27, 32, 35]. For example, Patel and co-workers [32]
measured 24 AHLs in eight bacterial cultures using a high-
resolution MS approach; they recognized C12-AHL in others
cultures, but not in Pseudomonas aeruginosa. The same was
found for the study by Hoang et al. [35] that quantified C12-
AHL in the Gram-negative endophytic bacterium
Paraburkholderia spp. As previously underlined, C7 HQ, 3-
oxo-C10-AHL and finally, C12-AHL could be the alternative
controlled factors expressed by mutant P. aeruginosa bacteria
responsible for their high tolerance to photodynamic therapy
and photo-oxidative stress induced by the therapy. These re-
sults lay the foundations for more in-depth studies on the lasI
and the rhlI QS signal systems.
An accurate quantitation of the molecules was achieved for
bacterial cultures WT-W9, WT-LB, RhlI-W9 and RhlI-LB,
and for human plasma samples using the NL and PI validated
MS method. We decided to validate the analytical method in
plasma QS-free matrix (belonging to healthy volunteers) be-
cause the ultimate goal of the study was to quantify QS mol-
ecules in plasma of patients affected by MOF. Many other
research groups have validated their analytical approaches in
bacterial cultures [28, 34, 35]. A comprehensive method for
QS compound quantitation in human samples is lacking
[23–25, 29]. Furthermore, we studied the Pseudomonas
aeruginosa QS molecule production because this is one of
the most common bacteria found to infect patients with sepsis
[49, 50]. Data shown in Table 6 indicate that C4-AHL was
detectable in all the samples within a concentration range of
4–7 μg/L, 3-oxo-C12-AHL in a range of 0–0.6 μg/L, and
finally, C7-HQ in a range between 2 and 18 μg/L. A general
tendency toward a decrease in QSmolecule concentration was
evidenced, showing that hemoperfusion of plasma of patients
with MOF was effective in the removal of QS compounds.
The monitoring of QS analytical standard molecules in
hemoperfused plasma samples from patients with MOF con-
firmed the ability of the MRM approach to quantify virulence
factors during sepsis with good sensitivity.
Conclusions
In conclusion, selective, sensitive and robust HPLC-TQ MS
methods were developed and applied to wild-type and mutant
P. aeruginosa bacterial cultures and to biological plasma sam-
ples. Thanks to untargeted NL and PI and targeted MRM
methods, different AHL and HQ molecules were identified,
characterized and quantified.
The HPLC-TQMS/MS analytical procedure was validated
in MRM, NL and PI scan mode. Experimental data indicated
that the method was suitable for the detection of low concen-
trations of AHLs and HQs in bacterial cultures of
Pseudomonas aeruginosa and biofluids in early stages of
sepsis-related multi-organ failure. Using the NL and PI scan
methods, it was possible to discover a new kind of species
whose presence within the sample was not predictable at the
beginning of the analysis. The presence of high concentrations
of C7 HQ, 3-oxo-C10-AHL and C12-AHL in mutant strains
of P. aeruginosa knocked for the production of C4-AHL
could be the starting point for a better understanding of how
bacteria exploit the controlled factors to survive and prolifer-
ate. The MRM approach was suitable for the detection of low
AHL and HQ levels within less abundant samples. The com-
parison between bacterial cultures and plasma samples
highlighted even more why high-sensitivity methods are es-
sential for plasma, given the concentration of a few micro-
grams per litre of the molecules of interest within the sample.
The three validated approaches were demonstrated to be
reproducible, repeatable, robust and sensitive enough to quan-
tify QS in real biological samples and, we think, to have ev-
idenced the possibility of applying them for solving practical
analytical problems with known limitations of sensitivity. The
LTQ-Orbitrap-HRMS platform has been confirmed as an in-
dispensable tool for investigating the fragmentation pathways
and confirming the detection of unexpected QS molecules.
In an on-going study in patients with MOF, we are dem-
onstrating the ability of hemoperfusion to reduce the QS
amount, underlining the physiopathological implications of
these findings. Here we have presented the usefulness of the
studied LC-MS approaches and applied them to real samples.
Dal Bello F. et al.
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